Literature DB >> 20804347

Evaluation of the introduction of a new treatment for the termination of pregnancy in The Netherlands.

Joseph F G M Brouns1, Matthe P M Burger, Wim J van Wijngaarden.   

Abstract

All hospital-based gynecologists in The Netherlands were sent a questionnaire on the termination of pregnancy with off-label drugs in the absence of treatment protocols. Response was received from 93.2% of the teaching hospitals and 87.9% of the non-teaching hospitals, thus representing practice of nearly all gynecologists working in The Netherlands. More than 40 different regimens were used for five different indications. Gynecologists embarked on a large number of different regimens of which a distressing number do not have any merits to be found in studies or guidelines illustrating that, without clear protocols or guidelines, the implementation of new medical treatments is potential haphazard and based on personal preference. Suboptimal treatment regimens will frustrate patients and doctors and deprive future patients from the most efficacious and patient friendly treatment regimes available.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20804347     DOI: 10.3109/00016349.2010.501856

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  Practice variation in the management of first trimester miscarriage in the Netherlands: a nationwide survey.

Authors:  Marianne A C Verschoor; Marike Lemmers; Malu Z Wekker; Judith A F Huirne; Mariëtte Goddijn; Ben Willem J Mol; Willem M Ankum
Journal:  Obstet Gynecol Int       Date:  2014-11-04

2.  Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013.

Authors:  Mette Løkeland; Tone Bjørge; Ole-Erik Iversen; Rupali Akerkar; Line Bjørge
Journal:  Int J Epidemiol       Date:  2017-04-01       Impact factor: 7.196

3.  Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial.

Authors:  Marianne A C Verschoor; Marike Lemmers; Patrick M Bossuyt; Giuseppe C M Graziosi; Petra J Hajenius; Dave J Hendriks; Marcel A H van Hooff; Hannah S van Meurs; Brent C Opmeer; Maurits W van Tulder; Liesanne Bouwma; Ruby Catshoek; Peggy Geomini; Ellen R Klinkert; Josje Langenveld; Theodoor E Nieboer; J Marinus van der Ploeg; Celine M Radder; Taeke Spinder; Lucy F van der Voet; Ben Willem J Mol; Judith A F Huirne; Willem M Ankum
Journal:  BMC Pregnancy Childbirth       Date:  2013-05-02       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.